RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
26 hedge funds and large institutions have $6.8M invested in Regulus Therapeutics in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Holders
26
Holding in Top 10
1
Calls
$329K
Puts
–
Top Buyers
| 1 | +$15.4K | |
| 2 | +$11.4K | |
| 3 | +$8.78K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.08K |
| 5 |
Renaissance Technologies
New York
|
+$3.4K |
Top Sellers
| 1 | -$37.4K | |
| 2 | -$31.1K | |
| 3 | -$5.78K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.33K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$43 |